0001776985 2025-10-21 2025-10-21 0001776985 1 2025-10-21 2025-10-21 0001776985 1 2025-10-21 2025-10-21 0001776985 2 2025-10-21 2025-10-21 iso4217:USD pure shares SC TO SC TO-T EX-FILING FEES 0001776985 BioNTech SE true true false false 1253580823.88 0.0001381 173119.51 1253580823.88 173119.51 0.00 173119.51 0.00 Transaction valuation estimated solely for purposes of calculating the filing fee. The transaction valuation was calculated by multiplying the product of (i) $5.39, which is the average of the high and low prices of ordinary shares of CureVac N.V. ("CureVac"), par value EUR0.12 per share ("CureVac shares") on October 15, 2025, as reported on the Nasdaq Global Market by (ii) 232,575,292, the number of CureVac shares outstanding on a fully diluted basis as of October 17, 2025. The calculation of the filing fee is based on information provided by CureVac. The filing fee was calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory for Fiscal Year 2026, effective October 1, 2025, issued August 25, 2025, by multiplying the transaction value by 0.00013810. true F-4 333-289468 2025-08-11 173119.51 true BioNTech SE F-4 333-289468 2025-08-11 187883.02 In connection with the Registration Statement on Form F-4 filed with the Securities and Exchange Commission on August 11, 2025 (File No. 333-289468), the registrant paid $187,883.02 with that submission. In connection with the Registration Statement on Form F-4 filed with the Securities and Exchange Commission on August 11, 2025 (File No. 333-289468), the registrant paid $187,883.02 with that submission.